Ledger.Open graph →
SEC Form D · filed May 31, 2019

Ashvattha Therapeutics, LLC

Offering
$6.4M
Sold
$250K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Kannan Rangaramanujam · Highland, MDExec · DirectorJeffrey Cleland · San Carlos, CAExec · DirectorBarbara Slusher · Redwood City, CADirectorSujatha Kannan · Highland, MDExec · DirectorSanju N. Bansal · MCLEAN, VAExec · DirectorQuentin Clark · San Francisco, CADirectorAndrew D. Bonanno · MOUNT KISCO, NYExec · DirectorMelissa A. Mcgrane · Miami, FLExec · DirectorJay Zaveri · Palo Alto, CADirectorAhmed D. Wahla · MOUNT KISCO, NYExec · DirectorMark N. Larow · MCLEAN, VAExec · DirectorClaiborne Williams · Los Angeles, CAExec · DirectorDavid A. Rosenblum · Austin, TXDirectorJay Zaveri · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗